Cargando…
Skin inflammation and impaired adipogenesis in a mouse model of acid ceramidase deficiency
Acid ceramidase catalyzes the degradation of ceramide into sphingosine and a free fatty acid. Acid ceramidase deficiency results in lipid accumulation in many tissues and leads to the development of Farber disease (FD). Typical manifestations of classical FD include formation of subcutaneous nodules...
Autores principales: | Rybova, Jitka, Kuchar, Ladislav, Sikora, Jakub, McKillop, William M., Medin, Jeffrey A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826362/ https://www.ncbi.nlm.nih.gov/pubmed/36083604 http://dx.doi.org/10.1002/jimd.12552 |
Ejemplares similares
-
Acid Ceramidase Deficiency: Bridging Gaps between Clinical Presentation, Mouse Models, and Future Therapeutic Interventions
por: Kleynerman, Annie, et al.
Publicado: (2023) -
Spinal muscular atrophy-like phenotype in a mouse model of acid ceramidase deficiency
por: Nagree, Murtaza S., et al.
Publicado: (2023) -
Acid ceramidase deficiency: Farber disease and SMA-PME
por: Yu, Fabian P. S., et al.
Publicado: (2018) -
Deletion of MCP-1 Impedes Pathogenesis of Acid Ceramidase Deficiency
por: Yu, Fabian P. S., et al.
Publicado: (2018) -
Recombinant Acid Ceramidase Reduces Inflammation and Infection in Cystic Fibrosis
por: Gardner, Aaron I., et al.
Publicado: (2020)